ArticleNature communications2023

Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering.

Derek Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.